Why T2 Biosystems Is Trading Higher By 18%; Here Are 28 Stocks Moving Premarket
Why T2 Biosystems Is Trading Higher By 18%; Here Are 28 Stocks Moving Premarket
為什麼 T2 生物系統的交易價格高於 18%;這裡有 28 隻股票推動市場前
Gainers
贏家
HHG Capital Corporation (NASDAQ:HHGC) shares rose 42.1% to $14.56 in pre-market trading.
Rubius Therapeutics, Inc. (NASDAQ:RUBY) rose 32% to $0.60 in pre-market trading after declining 7% on Thursday. Rubius Therapeutics recently discontinued ongoing Phase 1 trials of RTX-240 and RTX-224 in advanced solid tumors.
T2 Biosystems, Inc. (NASDAQ:TTOO) rose 18% to $0.1055 in pre-market trading after the company announced a distribution agreement in the Baltic Region. The company will sell T2Dx Instruments, along with T2Bacteria, T2Candida and T2Resistance Panels through the distributor.
Aqua Metals, Inc. (NASDAQ:AQMS) rose 15.9% to $0.98 in pre-market trading.
Ampio Pharmaceuticals, Inc. (NYSE:AMPE) rose 15.2% to $0.09 in pre-market trading.
Avenue Therapeutics...
HHG資本公司納斯達克(Sequoia Capital:HHGC)股價在盤前交易中上漲42.1%,至14.56美元。
Rubius治療公司納斯達克(Sequoia Capital:RUBY)在週四...
登入免費觀看全文
登入/註冊